Clinical laboratory parallels in women with polycystic ovary syndrome (PCOS) and metabolic syndrome (MS)

Abstract

PCOS (polycystic ovarian syndrome) in Women rates up to 33% prevalence of Metabolic Syndrome (MS). Worldwide, the prevalence of MS is associated with T2DM and obesity but some regional variations are reported as well. This condition is usually associated with long term consequences such as CVS, T2DM, psychological issues, cancer and sleep apnea. During the study, we evaluated 53 women, revealing Exceeded BMI 30kg/m2. Out of 53, in 13 patients diagnoses were T2DM, in 16 Insulin Resistance, in 22 Arterial Hypertension, in 17 increased triglycerides and in 23 reduced HDL levels among MS criteria.